Table of Contents
Clinical features | Treatment | Microscopic (histologic) description | Microscopic (histologic) images | Positive stains | Negative stains | Molecular / cytogenetics images | Additional referencesCite this page: Pregnancy related carcinoma. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/breastmalignantpregnancy.html. Accessed July 14th, 2017.
Clinical features
- Estimated incidence of 1 case per 3,000 pregnancies
- Increasing incidence due to delay of childbearing (Obstet Gynecol 2009;114:568)
- Associated with higher stage and larger primary tumors than non pregnancy associated tumors (Obstet Gynecol 2008;112:71)
- Similar features as breast carcinoma in other young women, and clinical course may not be as aggressive as initially reported (Cancer 2003;98:1055)
- Mammogram is less sensitive during pregnancy due to increased parenchymal density; ultrasound is best technique for evaluation of breast masses during pregnancy or lactation
- Diagnosis may be delayed (Cancer 2009;115:1174)
- Tumors usually contain rare fetal cells (Breast Cancer Res 2008;10:R14)
Treatment
- Sentinel lymph node mapping can be performed safely (Breast J 2008;14:250, Ann Surg Oncol 2007;14:218)
- Wait until second trimester to use chemotherapy (Cancer 2006;106:237, Eur J Surg Oncol 2009;35:215), which should be anthracycline based
- Delay until after delivery use of anti-folate (methotrexate) and anti-estrogen drugs (tamoxifen, Expert Opin Pharmacother 2009;10:2259), radiotherapy and Herceptin / trastuzumab (associated with anhydramnios, Ann Oncol 2008;19:607)
Microscopic (histologic) description
- 80% high grade
- Cancerization of lobules in 79%
Microscopic (histologic) images
Positive stains
- MUC2 (if during lactation)
- Variable HER2 (Virchows Arch 2003;443:44)
Negative stains
- Usually ER, PR, although these markers may underestimate tumor hormone dependence (Anticancer Res 2008;28:2447)
Molecular / cytogenetics images
Additional references







